{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:17:04Z","timestamp":1788268624723,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sapienza University of Rome","award":["Ateneo 2023"],"award-info":[{"award-number":["Ateneo 2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Metabolic-associated steatotic liver disease (MASLD) represents the most common chronic hepatopathy worldwide and an independent risk factor for cardiovascular disease and mortality, particularly when liver fibrosis occurs. Epigenetic alterations, such as DNA methylation, may influence MASLD susceptibility and progression; yet mechanisms underlying this process are limited. This study aimed to investigate whether active DNA demethylation in peripheral blood mononuclear cells (PBMCs) from individuals with MASLD, alongside the methylation and mRNA levels of inflammation- and fibrosis-related candidate genes, is associated with liver fibrosis. For this study, global demethylation intermediates (5-hydroxymethylcytosine [5hmC], 5-formylcytosine [5fC]) were quantified in PBMCs from 89 individuals with\/without MASLD using ELISA. Site-specific DNA methylation of SOCS3, SREBF1, and TXNIP was analyzed by mass spectrometry-based bisulfite sequencing; mRNA expression was assessed via RT-PCR. Individuals with MASLD and moderate-to-high fibrosis risk (estimated by the fibrosis non-alcoholic steatohepatitis (NASH) index, FNI) progressively exhibited greater global 5hmC and 5fC levels. Higher FNI was associated with reduced methylation of the SOCS3 gene and increased mRNA expression of the SOCS3, TXNIP, IL-6, and MCP-1 genes. In conclusion, elevated fibrosis risk in MASLD is associated with active global DNA demethylation, as well as differential methylation and expression patterns of genes, which are key regulators of inflammation and fibrosis. These epigenetic alterations in PBMCs may mirror DNA methylation changes in the liver, which may potentially contribute to liver fibrogenesis and represent novel biomarkers for MASLD progression toward fibrosis.<\/jats:p>","DOI":"10.3390\/ijms26031271","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:36:51Z","timestamp":1738557411000},"page":"1271","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD)"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-8568","authenticated-orcid":false,"given":"Ilaria","family":"Barchetta","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zampieri","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Agata","family":"Cimini","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-6963","authenticated-orcid":false,"given":"Sara","family":"Dule","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sentinelli","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes, Department of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Passarella","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Oldani","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsiaryna","family":"Karpach","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Bacalini","sequence":"additional","affiliation":[{"name":"IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-6078","authenticated-orcid":false,"given":"Marco Giorgio","family":"Baroni","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes, Department of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"},{"name":"Neuroendocrinology and Metabolic Diseases, IRCCS Neuromed, 86077 Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reale","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-8049","authenticated-orcid":false,"given":"Maria Gisella","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_5","first-page":"691","article-title":"MASLD: A Systemic Metabolic Disorder with Cardiovascular and Malignant Complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural History and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"9","author":"Shang","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","article-title":"Epigenetics in Human Obesity and Type 2 Diabetes","volume":"29","author":"Ling","year":"2019","journal-title":"Cell Metab."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Stols-Gon\u00e7alves, D., Meijnikman, A.S., Trist\u00e3o, L.S., Santos, C.L.D., Denswil, N.P., Verheij, J., Bernardo, W.M., and Nieuwdorp, M. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis-A Systematic Review. Cells, 13.","DOI":"10.3390\/cells13221893"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, H., Liu, Z., Fan, H., Guo, C., Zhang, X., Li, Y., Zhao, S., Dai, L., Zhao, M., and Zhang, T. (2024). Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD. J. Gastroenterol.","DOI":"10.1007\/s00535-024-02181-0"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13148-024-01670-6","article-title":"DNA methylation and type 2 diabetes: A systematic review","volume":"16","author":"Nadiger","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"ref_11","first-page":"49","article-title":"Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy and the Biomarker Potential","volume":"3","author":"Yang","year":"2022","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13148-021-01099-1","article-title":"Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus","volume":"13","author":"Zampieri","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2337\/db13-1916","article-title":"Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation","volume":"63","author":"Dhliwayo","year":"2014","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Carow, B., and Rottenberg, M.E. (2014). SOCS3, a Major Regulator of Infection and Inflammation. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00058"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","article-title":"Loss of SOCS3 in the Liver Promotes Fibrosis by Enhancing STAT3-Mediated TGF-\u03b21 Production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1080\/15548627.2021.1968608","article-title":"Impairment of ULK1 Sulfhydration-Mediated Lipophagy by SREBF1\/SREBP-1c in Hepatic Steatosis","volume":"17","author":"Nguyen","year":"2021","journal-title":"Autophagy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4239\/wjd.v12.i12.1979","article-title":"Thioredoxin Interacting Protein, a Key Molecular Switch Between Oxidative Stress and Sterile Inflammation in Cellular Response","volume":"12","author":"Mohamed","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1172\/JCI122462","article-title":"TGF-\u03b2-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis","volume":"130","author":"Dees","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"111475","DOI":"10.1016\/j.mad.2021.111475","article-title":"Role and mechanism of TXNIP in ageing-related renal fibrosis","volume":"196","author":"He","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/15592294.2016.1178418","article-title":"DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk","volume":"11","author":"Dayeh","year":"2016","journal-title":"Epigenetics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2213-8587(15)00127-8","article-title":"Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: A nested case-control study","volume":"3","author":"Chambers","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cabre, N., Luciano-Mateo, F., Chapski, D.J., Baiges-Gaya, G., Fernandez-Arroyo, S., Hernandez-Aguilera, A., Castane, H., Rodriguez-Tomas, E., Paris, M., and Sabench, F. (2022). Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147830"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13148-021-01129-y","article-title":"Differential DNA Methylation and Changing Cell-Type Proportions as Fibrotic Stage Progresses in NAFLD","volume":"13","author":"Johnson","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/15592294.2017.1294305","article-title":"Human Liver Epigenetic Alterations in Non-Alcoholic Steatohepatitis Are Related to Insulin Action","volume":"12","author":"Matte","year":"2017","journal-title":"Epigenetics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship Between Methylome and Transcriptome in Patients with Nonalcoholic Fatty Liver Disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23916","DOI":"10.1074\/jbc.M312676200","article-title":"A Choline-Deficient Diet in Mice Inhibits Neither the CDP-Choline Pathway for Phosphatidylcholine Synthesis in Hepatocytes Nor Apolipoprotein B Secretion","volume":"279","author":"Kulinski","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-Adenosylmethionine Metabolism and Liver Disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.11.024","article-title":"Hepatic Stellate Cell Transdifferentiation Involves Genome-Wide Remodeling of the DNA Methylation Landscape","volume":"64","author":"Page","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20170362","DOI":"10.1098\/rstb.2017.0362","article-title":"Modelling Non-Alcoholic Fatty Liver Disease in Human Hepatocyte-Like Cells","volume":"373","author":"Lyall","year":"2018","journal-title":"Philos. Trans. R. Soc. B"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15592294.2019.1649527","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) Is Associated with Dynamic Changes in DNA Hydroxymethylation","volume":"15","author":"Lyall","year":"2020","journal-title":"Epigenetics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/oby.22667","article-title":"Association of Hepatic Global DNA Methylation and Serum One-Carbon Metabolites with Histological Severity in Patients with NAFLD","volume":"28","author":"Lai","year":"2020","journal-title":"Obesity"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"G531","DOI":"10.1152\/ajpgi.00342.2020","article-title":"GCSF Deficiency Attenuates Nonalcoholic Fatty Liver Disease through Regulating GCSFR-SOCS3-JAK-STAT3 Pathway and Immune Cells Infiltration","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1480","DOI":"10.1097\/MD.0000000000001480","article-title":"Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins","volume":"94","author":"Pirola","year":"2015","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","article-title":"Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet","volume":"51","author":"Pogribny","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/DMSO.S349153","article-title":"Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Metab","volume":"15","author":"Guo","year":"2022","journal-title":"Syndr. Obes."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic Steatosis Index: A Simple Screening Tool Reflecting Nonalcoholic Fatty Liver Disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","article-title":"Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis","volume":"21","author":"Tavaglione","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_40","unstructured":"Rosner, B. (2011). Fundamentals of Biostatistics, Brooks\/Cole. [7th ed.]."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1271\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:25:10Z","timestamp":1760027110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/1271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26031271"],"URL":"https:\/\/doi.org\/10.3390\/ijms26031271","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}